Future Google supplier Kairos Power inked a deal with Samsung C&T to help build its first 50-megawatt nuclear power plant.
$KAPA
Price history, market instrument context, member research, and related headlines in one place.
KAPA key statistics
NYSE AmericanUSD
52-week range
$0.71080%$9.17
Latest session $0.7108–$0.795Kairos Pharma, Ltd. (KAPA) is a stock instrument quoted on NYSE American in USD. The most recently published price is $0.743, down $0.09 (10.34%) from the previous close of $0.8287. It has traded between $0.7108 and $0.795 in the latest session. Over the past year it has ranged from $0.7108 to $9.17, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 285.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Kairos Pharma (KAPA) will do a 1-for-7 reverse stock split Sept. 1, 2026 to boost share price and NYSE compliance.
Kairos Pharma to conduct 1-for-7 reverse stock split — See source for full details.
Loading $KAPA research…